Organigram Global (OGI) Goodwill (2018 - 2026)
Organigram Global (OGI) posted quarterly Goodwill of $38.3 million for Q1 2026, up 1.69% on a QoQ basis from $37.7 million in Q4 2025.
Organigram Global (OGI) Goodwill (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Goodwill for 4 consecutive years, with $38.3 million the latest figure, recorded in Q1 2026.
- Quarterly Goodwill changed N/A year-over-year to $38.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.3 million (changed N/A YoY) and the FY2025 annual result came in at $37.7 million, changed N/A from the prior year.
- Goodwill rose to $38.3 million in Q1 2026 per OGI's latest filing, from $37.7 million in the prior quarter.
- Over the last five years, Goodwill for OGI reached as high as $38.3 million in Q1 2026 and fell as low as $10.1 million in Q3 2022.
- A 3-year average of $31.1 million and a median of $37.9 million in 2025 frame the typical range for Goodwill.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.30 Mn |
| Dec 31, 2025 | 37.66 Mn |
| Sep 30, 2025 | 38.17 Mn |
| Aug 31, 2022 | 10.11 Mn |
| Aug 31, 2018 | 708,005.37 |